在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

  1. 首頁
  2. 蛋白
  3. 重組蛋白
  4. Recombinant Human Collagen alpha-1(VII) chain (COL7A1)

Recombinant Human Collagen alpha-1(VII) chain (COL7A1)

  • 中文名稱：
  • 貨號：
    CSB-YP733975HU
  • 規(guī)格：
  • 來源：
    Yeast
  • 其他：
  • 中文名稱：
  • 貨號：
    CSB-EP733975HU
  • 規(guī)格：
  • 來源：
    E.coli
  • 其他：
  • 中文名稱：
  • 貨號：
    CSB-EP733975HU-B
  • 規(guī)格：
  • 來源：
    E.coli
  • 共軛：
    Avi-tag Biotinylated

    E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.

  • 其他：
  • 中文名稱：
  • 貨號：
    CSB-BP733975HU
  • 規(guī)格：
  • 來源：
    Baculovirus
  • 其他：
  • 中文名稱：
  • 貨號：
    CSB-MP733975HU
  • 規(guī)格：
  • 來源：
    Mammalian cell
  • 其他：

產(chǎn)品詳情

  • 純度：
    >85% (SDS-PAGE)
  • 基因名：
    CO7A1
  • Uniprot No.：
  • 別名：
    Collagen alpha-1(VII; chain; Long-chain collagen; LC collagen; COL7A1
  • 種屬：
    Homo sapiens (Human)
  • 蛋白標簽：
    Tag?type?will?be?determined?during?the?manufacturing?process.
    The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
  • 產(chǎn)品提供形式：
    Liquid or Lyophilized powder
    Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
  • 復(fù)溶：
    We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
  • 儲存條件：
    Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
  • 保質(zhì)期：
    The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
    Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
  • 貨期：
    Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
    Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
  • 注意事項：
    Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
  • Datasheet ：
    Please contact us to get it.

產(chǎn)品評價

靶點詳情

  • 功能：
    Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen.
  • 基因功能參考文獻：
    1. Case report of 2 potentially pathogenic variants in COL7A1 occurring on the same allele in members of a family with epidermolysis bullosa pruriginosa and autosomal dominant inheritance. PMID: 29504492
    2. In summary, we present 7 novel COL7A1 mutations in a cohort of 17 Mexican RDEB patients, expanding the mutation spectrum in this disease. PMID: 29473190
    3. Case Report: Epidermolysis ullosa acquisita with previously unrecognized mild dystrophic EB and biallelic COL7A1 missense mutations. PMID: 29182795
    4. Mutation in COL7A1 gene is associated with Recessive Dystrophic Epidermolysis Bullosa. PMID: 29531004
    5. High chimeric COL7A1-UCN2 recurrence is associated with cancer stem cell transition, promoted epithelial-mesenchymal transition in laryngeal cancer. PMID: 29499655
    6. three unrelated patients with two identical pathogenic compound heterozygous mutations in the COL7A1 gene developed different clinical forms of dystrophic epidermolysis bullosa-epidermolysis bullosa pruriginosa and mild recessive non-Hallopeau-Siemens. PMID: 29272047
    7. Type VII collagen is distributed particularly at the strained parts of the accommodation system. Type VII collagen was associated with various basement membranes and with ciliary zonules. PMID: 29490344
    8. specifically binds and sequesters the innate immune activator cochlin in the lumen of lymphoid conduits PMID: 29305555
    9. COL7A1 editing via CRISPR/Cas9 in recessive dystrophic epidermolysis bullosa patients' keratinocytes in vitro has been reported. PMID: 28800953
    10. Patients with RDEB carry mutations in the COL7A1 gene encoding for type VII collagen, the main component of anchoring fibrils, microstructures responsible for the anchorage of the epidermis to the underlying dermis. [review] PMID: 28126522
    11. expression restored to recessive dystrophic epidermolysis bullosa skin by topical gene therapy PMID: 27117059
    12. we have identified a novel glycine substitution mutation of the COL7A1 gene in two unrelated Scottish families with a DDEB phenotype. This mutation abolishes the donor splice site and results in in-frame exon skipping. This leads to dominant negative interference between the wild-type and truncated-type collagen proteins resulting in a mild phenotype. PMID: 27790721
    13. Case Report: glycine substitution specific to COL7A1, exon 110, was identified in a Chinese family with epidermolysis bullosa pruriginosa. PMID: 28164502
    14. COL7A1 harbored mutations in the overwhelming majority of patients with dystrophic epidermolysis bullosa, and most of them in this Iranian cohort were consistent with autosomal recessive inheritance. Ninety percent of these mutations were homozygous recessive, reflecting consanguinity in these families. PMID: 27899325
    15. miR-29 Regulates COL7A1 in Recessive Dystrophic Epidermolysis Bullosa, directly through targeting its 3' untranslated region at two distinct seed regions and indirectly through targeting an essential transcription factor required for basal COL7A1 expression, SP1. PMID: 27328306
    16. A total of 50% of the pro-alpha1 (VII) procollagen chains will contain the dominant COL7A1 mutation if a DDEB patient carries one mutant COL7A1 in 100% of skin cells, which will lead to dystrophic epidermolysis bullosa PMID: 26289024
    17. The results in these two brothers show that COL7A1 mutation leads to persistent blistering in adulthood indicating that DEB may persist throughout life in a mild form. PMID: 26595603
    18. This study is conducive to highlighting the phenotypic diversity of EBP, expanding the database on COL7A1 mutations in EBP and laying the foundation for this family's prenatal genetic counselling. PMID: 25556825
    19. TANGO1 is thus pivotal in concentrating procollagen VII in the lumen and recruiting ERGIC membranes on the cytoplasmic surface of the endoplasmic reticulum. PMID: 26568311
    20. Novel dystrophic epidermolysis bullosa COL7a1 framshift mutation c.5493delG (p.K1831Nfs*10) in exon 64 leads to a premature termination codon located 10 amino acids downstream in exon 64 (p.K1831Nfs*10) and is expected to result in a loss of function. PMID: 26586712
    21. In conclusion, we identified a Japanese founder recurrent mutation of c.6216 + 5G > T, inducing aberrant splicing of COL7A1 and tending to cause a mild phenotype of recessive dystrophic epidermolysis bullosa PMID: 26472200
    22. COL7A1 mutations have a role in Recessive Dystrophic Epidermolysis Bullosa and can be corrected meganuclease-mediated homology-directed repair PMID: 26897595
    23. Type VII collagen suppresses TGFbeta signaling and angiogenesis in cutaneous SCC (squamous cell carcinoma). Patients with recessive dystrophic epidermolysis bullosa (RDEB) SCC may benefit from anti-angiogenic therapy. PMID: 26476432
    24. COL7A1 mutation was diagnosed with next generation sequencing in patient with dystrophic epidermolysis bullosa. PMID: 25425313
    25. Collagen Type VII missense mutation is responsible for the development of recessive bullous epidermolysis. PMID: 25639640
    26. A novel dominantnegative heterozygous acceptor splice site mutation in the COL7A1 gene (IVS671G>T) was found in both our patient and his youngest son. PMID: 25566895
    27. Gene therapy is successful in the treatment of hereditary epidermolysis bullosa dystrophica. PMID: 26066885
    28. autoantibodies to COL7, independent of the targeted epitopes, induce blisters both ex vivo and in vivo PMID: 25689103
    29. Results suggest that In children with a moderate form of DEB with no or moderate skin fragility, a glycine substitution near the THD interruption domain of the collagen VII leading to thermolabile protein could explain this phenomenon PMID: 24252097
    30. The central collagenous domain of Col7 contains several interruptions of the collagen triple helix PMID: 24810542
    31. anti-type VII collagen autoantibodies fluctuated in parallel with disease activity in epidermolysis bullosa acquisita PMID: 24127822
    32. Study demonstrated that versican, TGFbeta1, Col7A1 and ITGbeta3 are up-regulated in isolated Cancer stem cells. PMID: 24927163
    33. Case Report: hot spot mutation c.6127G>A in COL7A1 leads to dominant dystrophic epidermolysis bullosa associated with intracellular accumulation of pro-collagean VII. PMID: 24794830
    34. TGM2 was identified as a stable interaction partner of collagen VII and is reduced in recessive dystrophic epidermolysis bullosa. PMID: 24732400
    35. The mutations detected in our 17 DEB patients highlight the presence of both mild (DDEB) and severe phenotypes (RDEB-O and RDEB-sev gen), confirming that a more severe involvement of the oropharyngeal mucosa occurs in RDEB. PMID: 24210835
    36. SLCO1B3 expression and promoter activity are modulated by COL7A1 in tumor keratinocytes isolated from recessive dystrophic epidermolysis bullosa. PMID: 24357722
    37. Bullous dermolysis of the newborn (BDN) is a subtype of dystrophic epidermolysis bullosa caused by mutations in type VII collagen resulting in disorganized anchoring fibrils and sublamina densa blister formation. PMID: 24117545
    38. We show that revertant recessive dystrohic epidermolysis bullosa keratinocytes expressing functional C7 can be reprogrammed into induced pluripotent stem cells and self-corrected keratinocytes can be differentiated into epidermal or hematopoietic cells. PMID: 24317394
    39. analysis of COL7A1 mutations in patients with recessive dystrophic epidermolysis bullosa PMID: 24213372
    40. data further enhance the mutation spectrum of the LAMB3 and the COL7A1 genes, and also underscore the crucial roles of these genes in pathogenesis of epidermolysis bullosa PMID: 23769655
    41. Our long-term observational study showed that this in-frame exon skipping mutation was conversely highly predictive of the pruriginosa phenotype and characterized by a very variable phenotype in terms of severity of disease. PMID: 23688405
    42. Data suggest that, of the five basement membrane types present in term placental tissue and fetal membranes, just one, that associated with amnion epithelium, expresses type VII collagen. PMID: 23834951
    43. immortalized and cloned recessive dystrophic epidermolysis bullosa keratinocytes carrying the c.6527insC mutation PMID: 23947675
    44. We report the first case of HS-RDEB homozygous PTC mutations of 5818delC in both COL7A1 alleles. PMID: 23679163
    45. Novel deletion mutation (c.3717del5) in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa. PMID: 22974128
    46. We describe three families with multiple affected members in which epidermolysis bullosa prurigosa variant shows autosomal-dominance and all three previously unreported COL7A1 mutations were identified. PMID: 23106673
    47. The wide diversity of clinical phenotypes with one underlying genotype demonstrates that COL7A1 mutations are incompletely penetrant and strongly suggests that other genetic and environmental factors influence clinical presentation. PMID: 22515571
    48. Loss of collagen VII has a global impact on the cellular microenvironment in recessive dystrophic epidermolysis bullosa patients. PMID: 23591773
    49. Mutation in COL7A1 caused a broad range of severity of disease in a family with pretibial epidermolysis bullosa. PMID: 23624125
    50. We report six Chinese cases with Epidermolysis Bullosa Pruriginosa, who had four novel and two previously reported mutations leading to glycine substitutions of COL7A1. PMID: 23397949

    顯示更多

    收起更多

  • 相關(guān)疾病：
    Epidermolysis bullosa dystrophica, autosomal dominant (DDEB); Epidermolysis bullosa dystrophica, autosomal recessive (RDEB); Transient bullous dermolysis of the newborn (TBDN); Epidermolysis bullosa dystrophica, pretibial type (PR-DEB); Epidermolysis bullosa dystrophica, Bart type (B-DEB); Epidermolysis bullosa pruriginosa (EBP); Nail disorder, non-syndromic congenital, 8 (NDNC8); Epidermolysis bullosa dystrophica, with subcorneal cleavage (EBDSC)
  • 亞細胞定位：
    Secreted, extracellular space, extracellular matrix, basement membrane.
  • 數(shù)據(jù)庫鏈接：

    HGNC: 2214

    OMIM: 120120

    KEGG: hsa:1294

    STRING: 9606.ENSP00000332371

    UniGene: Hs.476218



主站蜘蛛池模板： 熟妇丰满多毛的大隂户| 精品国产一区二区三区无码| 久久婷婷五月综合色中文字幕| 久久er99热精品一区二区| 亚洲国产成人av网站| 男女做爰无遮挡性视频| 国产av一区二区三区日韩| 亚洲 中文 欧美 日韩 在线| 欧美成人a天堂片在线观看| 少妇激情作爱视频| 18禁止看的免费污网站| 性xxxx欧美老妇胖老太269| 日本一卡2卡三卡4卡免费网站| 无码色av一二区在线播放| 精品久久久久中文字幕一区| av大片在线无码永久免费| 国产在线无码视频一区二区三区| 久久国产加勒比精品无码| 18禁网站免费无遮挡无码中文| 97人洗澡人人澡人人爽人人模| 最新精品国偷自产在线老年人| 欧美日韩精品| 久久精品夜色噜噜亚洲a∨| 99九九99九九视频精品| 日韩好精品视频你懂的| 小sao货水好多真紧h视频| 婷婷丁香六月激情综合在线人| 免费观看男女性高视频| 玩弄白嫩少妇xxxxx性| 日韩人妻无码精品免费shipin| 亚洲国产成人精品无码一区二区| 大又大又粗又硬又爽少妇毛片| 国产亚洲精品aaaa片小说| 国产综合有码无码视频在线| 无码帝国www无码专区色综合| 亚洲a∨无码无在线观看| 欧美va亚洲va在线观看日本| 肥白大屁股bbwbbwhd| 国产精品一区二区久久国产| 亚洲精品国产精品乱码不卡| 精品国产一区二区三区av色诱|